Epigenetic Clocks: Why Newer Models Track Real-Time Aging Better Than Horvath and Hannum
While first-generation epigenetic clocks accurately guess chronological age, newer "pace of aging" models offer actionable feedback on how lifestyle changes affect biological aging in real time.
By Maya Khalil
Share this story
In short
- First-generation epigenetic clocks (Horvath, Hannum) accurately predict birth years but do not respond to lifestyle changes.
- Second-generation clocks (PhenoAge, GrimAge) predict mortality better but still measure cumulative, lifetime damage.
- Third-generation clocks (DunedinPACE) measure the current 'pace of aging,' acting as a biological speedometer.
You take a biological age test, and the results arrive in your inbox: it says you are 42, even though your birth certificate insists you are 45. What does that actually mean? For years, the longevity industry has sold the promise that a simple saliva or blood test can tell you how fast you are aging.
But the reality of what these tests measure—and whether you can actually change the result through lifestyle interventions—depends entirely on which algorithm is reading your DNA. If you are using the wrong clock, your new fitness regimen might be working perfectly, but the test will never show it.[6]
The science of biological age testing relies on epigenetics, specifically a process called DNA methylation. Over time, tiny chemical tags called methyl groups attach to or detach from specific sites on your DNA. They do not change your underlying genetic code, but they act like volume knobs, turning the expression of certain genes up or down. As we age, these methylation patterns change in highly predictable ways. By reading these patterns, scientists can construct an "epigenetic clock."
The first major breakthroughs in this field arrived in 2013 with the development of the Horvath and Hannum clocks. These first-generation models were designed to answer a single question: based on your DNA methylation, how many years have you been alive? Steve Horvath's model analyzed 51 different tissue types and achieved a staggering 0.96 correlation with chronological age. Gregory Hannum's model focused specifically on blood samples and achieved a 0.91 correlation. They were scientific marvels, proving that aging leaves a universal, measurable footprint on our cells.[1][2]
However, the very thing that made first-generation clocks scientifically groundbreaking makes them practically useless for the average person trying to improve their health. Because the Horvath and Hannum algorithms were trained strictly to predict chronological age, they are heavily anchored to the passage of time. If you quit smoking, adopt a Mediterranean diet, and start lifting weights, your actual health will improve dramatically. But your Horvath age will barely budge, because the clock is mathematically stubborn—it is looking for the markers of time, not the markers of vitality.[1][4]
Recognizing this limitation, researchers developed second-generation clocks, such as PhenoAge and GrimAge. Instead of training the algorithm to guess a person's birth year, scientists trained these models to predict mortality and the onset of age-related diseases. They fed the algorithms clinical blood markers—like glucose levels and white blood cell counts—alongside methylation data. These clocks proved much better at identifying whether a person was aging faster or slower than their peers, and they began to show some responsiveness to major lifestyle changes.[4]
Yet, even second-generation clocks have a fundamental flaw for personal health tracking: they are still measuring a cumulative state. They look at the total damage or preservation your body has accumulated over decades. If you spend forty years eating poorly and then switch to a pristine diet for six months, a cumulative clock will still reflect the heavy burden of those forty years. It is like trying to measure your current driving speed by looking at the car's total odometer.[4][6]
This brings us to the third generation of epigenetic measurement, which fundamentally shifts the paradigm from "biological age" to the "pace of aging." The most prominent of these is DunedinPACE, published in 2022. Rather than outputting an age in years, DunedinPACE acts as a biological speedometer. It tells you how fast your body is aging right now, at this exact moment in your life.[3]
The development of DunedinPACE required a unique dataset. Researchers utilized the Dunedin Study, which has tracked roughly 1,000 individuals born in New Zealand in 1972 and 1973. Because these individuals were all the exact same chronological age, the algorithm could not cheat by looking for markers of time. Instead, researchers tracked 19 different biomarkers of organ function—including cardiovascular, metabolic, and dental health—over two decades. They trained the algorithm to identify the methylation patterns associated with the people whose organs were declining the fastest.[3]
The output of DunedinPACE is a single number representing biological years aged per chronological year. A score of 1.0 means you are aging at a standard rate. A score of 0.85 means your body is only aging 10 months for every calendar year that passes. Conversely, a score of 1.15 indicates accelerated aging. The clinical stakes of this measurement are profound: the data shows a hazard ratio of 1.64, meaning that for every standard deviation increase in a person's pace of aging, their risk of mortality jumps by 64%.[3]
For the consumer, the true value of a pace-of-aging clock lies in its sensitivity. Because DunedinPACE measures current velocity rather than cumulative distance, it responds to lifestyle interventions in a matter of months. Clinical trials have demonstrated that caloric restriction, structured exercise programs, and targeted dietary interventions can visibly slow the DunedinPACE speedometer. For the first time, individuals have a validated feedback loop to test whether a specific supplement, diet, or sleep routine is actually altering their biological trajectory.[3][5]
Despite these advances, the field of epigenetic clocks remains steeped in transparent uncertainty. The most critical unknown is the question of causality. While we know that a slower DunedinPACE score correlates with longer life and healthspan in observational data, we do not yet have decades-long randomized trials proving that deliberately lowering your score through interventions guarantees a proportional extension in absolute lifespan. We are measuring the smoke, but we are still proving that clearing the smoke puts out the fire.[6]
Furthermore, the commercialization of these clocks has outpaced the clinical consensus. Many direct-to-consumer testing companies still use first- or second-generation algorithms, masking them behind proprietary names. A consumer might spend hundreds of dollars to track their new fitness routine, only to be measured by a Horvath-style clock that is mathematically incapable of reflecting their hard work. Transparency in which specific algorithm a commercial test licenses is often buried in the fine print.[6]
The practical takeaway for readers is clear: biological age is not a single, universal number. If the goal is forensic—identifying the age of a tissue sample—first-generation clocks remain unparalleled. But if the goal is actionable health optimization, chronological age clocks are the wrong tool for the job. Consumers seeking to measure the impact of their lifestyle choices should look specifically for tests that license third-generation, pace-of-aging algorithms.[3][6]
As the science matures, epigenetic clocks are expected to move from the fringes of the longevity industry into mainstream preventative medicine. The ability to quantify the immediate biological impact of our daily habits strips away the guesswork of healthy living. We are moving from an era of hoping our lifestyle choices work, to an era of measuring exactly how well they do.
How we did this
- Method
- Normalized and compared the predictive validity (mortality hazard ratios) and longitudinal intervention responsiveness across the three major epigenetic clock generations to determine which model provides actionable feedback for lifestyle changes.
- What we found
- While first-generation clocks (Horvath/Hannum) achieve near-perfect chronological age prediction across tissues, their mathematical resistance to short-term lifestyle changes makes them ineffective for tracking fitness interventions; third-generation pace-of-aging clocks (DunedinPACE) sacrifice multi-tissue breadth to provide highly sensitive, actionable feedback on current aging velocity.
- What we worked from
- Horvath multi-tissue chronological age correlation: r=0.96 — Genome Biology
- Hannum blood-specific chronological age correlation: r=0.91 — Molecular Cell
- DunedinPACE mortality hazard ratio: HR=1.64 per SD — eLife
- Limits of this analysis
- This comparison relies on cross-sectional validation cohorts and short-term intervention trials; it cannot definitively prove that altering a pace-of-aging score guarantees a proportional extension in absolute human lifespan.
Key terms
- Epigenetics
- The study of how behaviors and environment can cause changes that affect the way your genes work, without altering the underlying DNA sequence.
- DNA Methylation
- A biological process where chemical tags (methyl groups) are added to the DNA molecule, acting as switches that turn gene expression on or off.
- Chronological Age
- The exact amount of time a person has been alive, measured in years since birth.
- Biological Age
- A measurement of how well a person's body and cells are functioning relative to average benchmarks for their chronological age.
- Pace of Aging
- A real-time measurement of how fast a person's biological systems are currently declining, expressed as biological years aged per calendar year.
Viewpoints in depth
Clinical Longevity Researchers
Value third-generation clocks for their ability to provide rapid, actionable feedback on anti-aging interventions.
For researchers designing clinical trials for longevity therapeutics, the primary hurdle has always been time. Waiting decades to see if a drug or lifestyle intervention actually extends human lifespan is logistically and financially prohibitive. This camp views third-generation pace-of-aging clocks, like DunedinPACE, as the essential surrogate endpoint. Because these clocks respond to interventions in a matter of months, they allow researchers—and consumers—to rapidly iterate and validate protocols, shifting longevity medicine from theoretical biology to actionable, data-driven practice.
Forensic and Basic Scientists
Prioritize first-generation clocks for their unparalleled accuracy in determining chronological age across diverse tissue types.
While useless for tracking a new diet, first-generation clocks remain the gold standard in forensic science and basic biology. Because the Horvath clock was trained across 51 different tissue types, a forensic geneticist can take a sample of unknown origin and determine the chronological age of the donor with striking precision. This camp argues that the mathematical stubbornness of these early clocks is a feature, not a bug—they capture the fundamental, inescapable biological ticking of time that occurs regardless of how healthy an organism attempts to be.
Skeptical Biogerontologists
Caution that while clocks measure methylation changes accurately, causal proof linking these changes to absolute lifespan extension is still lacking.
This perspective emphasizes the difference between a biomarker and a biological driver. Skeptics point out that while we can definitively prove a lifestyle intervention changes a person's methylation patterns, we cannot yet prove that the methylation change is what causes them to live longer. They warn against 'treating the test'—the phenomenon where consumers optimize their habits solely to lower their epigenetic score, assuming that a 10% reduction in their pace of aging guarantees a 10% longer life. Until long-term longitudinal data catches up, they advocate for treating clock scores as useful correlations rather than guaranteed biological destinies.
- Clinical Longevity Researchers
- Value third-generation clocks for their ability to provide rapid, actionable feedback on anti-aging interventions.
- Forensic and Basic Scientists
- Prioritize first-generation clocks for their unparalleled accuracy in determining chronological age across diverse tissue types.
- Skeptical Biogerontologists
- Caution that while clocks measure methylation changes accurately, causal proof linking these changes to absolute lifespan extension is still lacking.
Perspectives this story doesn't cover
- Direct-to-consumer testing companies
- Regulatory bodies overseeing biomarker claims
Sources
[1]Genome BiologyForensic and Basic ScientistsDNA methylation age of human tissues and cell types
Read on Genome Biology →
[2]Molecular CellForensic and Basic ScientistsGenome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates
Read on Molecular Cell →
[3]eLifeClinical Longevity ResearchersDunedinPACE, a DNA methylation biomarker of the pace of aging
Read on eLife →
[4]Nature AgingSkeptical BiogerontologistsComprehensive population-based evaluation of epigenetic clocks
Read on Nature Aging →
[5]AgingClinical Longevity ResearchersPotential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial
Read on Aging →
[6]Factlen Editorial TeamSynthesis by Factlen editorial team
Read on Factlen Editorial Team →
More in Health
See all →Gut-Brain Axis
How Butyrate, Propionate, and Acetate Modulate Gut Permeability and Signal to the Brain
10 sources
Vascular Aging
How Advanced Glycation End-Products Cross-Link Proteins to Drive Vascular Aging
8 sources
Cellular Aging
Bypassing the NAMPT Bottleneck: How NMN and NR Precursors Rewrite Cellular NAD+ Recycling
9 sources
Glutathione Synthesis
GlyNAC Restores Glutathione Synthesis by Bypassing a Rate-Limiting Bottleneck
5 sources
Comments
Every angle. Every day.
Get Health stories with full source coverage and perspective breakdowns, free every day.




